中文

Hong Kong Stocks · Free Data Page

BEONE MEDICINES 06160

BEONE MEDICINES: FY2025 revenue $5.28B (+39.80% YoY); net income $286.9M; all 17 risk checks passed with 0 alerts; no TTM dividend.
Close PriceHK$231.60Day +10.18%Market CapHK$357.2BP/E69.7xTTMP/B8.80xROE (FY2025)7.5%Avg. equity

Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.

Want the full AI research report for BEONE MEDICINES?

This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.

New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.

10-Year FinancialsFY2016–2025

Financial statements are reported in USD, while share price and market cap are quoted in HKD.

Key Multi-Year Facts

  • Revenue moved from $1.1M in FY2016 to $5.28B in FY2025 (9-year CAGR +157.3%).
  • Net income was negative in FY2016, FY2017, FY2018, FY2019, FY2020, FY2021, FY2022, FY2023, FY2024.

Latest 5 Fiscal Years

Fiscal Year20212022202320242025
Revenue (USD B)1.181.422.463.785.28
YoY280.8%20.4%73.7%53.7%39.8%
Net Income (USD B)-1.46-2.00-0.88-0.640.29
Operating Cash Flow (USD B)-8.28-10.4-8.20-1.017.93
ROE-29.2%-38.1%-22.3%-18.8%7.5%
Gross Margin86.0%79.8%84.5%84.3%87.3%
Net Margin-123.9%-141.5%-35.9%-17.1%5.4%
Debt-to-Assets28.2%31.3%39.1%43.7%46.7%
Show all 10 fiscal years
Fiscal Year2016201720182019202020212022202320242025
Revenue (USD B)0.000.240.200.430.311.181.422.463.785.28
YoY—22179.2%-16.8%116.0%-27.9%280.8%20.4%73.7%53.7%39.8%
Net Income (USD B)-0.12-0.09-0.67-0.95-1.60-1.46-2.00-0.88-0.640.29
Operating Cash Flow (USD B)-0.620.08-3.76-5.23-8.37-8.28-10.4-8.20-1.017.93
ROE-33.8%-18.2%-55.9%—-41.3%-29.2%-38.1%-22.3%-18.8%7.5%
Gross Margin100.0%97.9%85.5%83.4%77.1%86.0%79.8%84.5%84.3%87.3%
Net Margin-11141.8%-39.1%-339.9%-221.5%-517.0%-123.9%-141.5%-35.9%-17.1%5.4%
Debt-to-Assets13.0%34.6%22.0%—30.9%28.2%31.3%39.1%43.7%46.7%

Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings

Risk ChecklistAs of 2026-11-05

Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).

0Alert 0Watch 16Pass 1N/A

Checked across financial quality, solvency, going concern, and HKEX announcements (modified audit opinion, profit warning, suspension, auditor change) with no alerts or watch items triggered.

An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.

Dividends

No dividends paid over the trailing 12 months.

Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.

More data: All research reports · Sector leaders · Market hours & holidays.

Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.